1. 1849 Italian observational study of Eribulin Mesylate in patients with advanced breast cancer: ESEMPiO study. (September 2015) Authors: Barni, S.; Fontanella, C.; Del Mastro, L.; Livraghi, L.; Morritti, M.; Pizzuti, L.; Michelotti, A.; Lutrino, E.S.; Ciccarese, M.; Musolino, A.; Quercia, S.; Garrone, O.; Pellegrino, A.; Pistelli, M.; Martella, F.; Iezzi, L.; Mentuccia, L.; Latorre, A.; D'Onofrio, L.; Porcu, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1851 Safety analysis, correlation with response and previous treatments of the association of everolimus (EVE) and exemestane (EXE) in 181 metastatic breast cancer patients (MBC). (September 2015) Authors: Moscetti, L.; Vici, P.; Sperduti, I.; Fabbri, M.A.; Natoli, C.; Mancini, M.L.; Sini, V.; D'Onofrio, L.; Pizzuti, L.; Vaccaro, A.; Magnolfi, E.; Magri, V.; Trenta, P.; Ramponi, S.; Roma, C.; Ruggeri, E.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1950 Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. (September 2015) Authors: Gamucci, T.; Mentuccia, L.; Vici, P.; Iezzi, L.; Sperduti, I.; Astone, A.; Marchetti, P.; Pizzuti, L.; Michelotti, A.; Sini, V.; Cassano, A.; Ciancola, F.; Quadrini, S.; Moscetti, L.; Landucci, E.; Sergi, D.; Magnolfi, E.; Natoli, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Calibration of systematics in constraining modified gravity models with galaxy cluster mass profiles. Issue 4 (16th April 2020) Authors: Pizzuti, L.; Sartoris, B.; Borgani, S.; Biviano, A. Journal: Journal of cosmology and astroparticle physics Issue: Volume 2020:Issue 4(2020) Page Start: 024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Laminar burning velocity and flammability limits in biogas: A literature review. (September 2016) Authors: Pizzuti, L.; Martins, C.A.; Lacava, P.T. Journal: Renewable & sustainable energy reviews Issue: Volume 62(2016:Sep.) Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience. (October 2016) Authors: Moscetti, L.; Vici, P.; Gamucci, T.; Natoli, C.; Cortesi, E.; Marchetti, P.; Santini, D.; Giuliani, R.; Sperduti, I.; Mauri, M.; Pizzuti, L.; Mancini, M.L.; Fabbri, M.A.; Magri, V.; Iezzi, L.; Sini, V.; D'Onofrio, L.; Mentuccia, L.; Vaccaro, A.; Ramponi, S. Journal: Breast Issue: Volume 29(2016) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗